Procyrion
PrivateLast Round
Series E
Feb 5, 2024
Total Funding Raised
$114.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Procyrion operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series E round in February 2024.
Procyrion is a medical device company that develops percutaneous mechanical circulatory support technology for patients with cardiac and renal impairment.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Procyrion Comparables
Compare Procyrion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Puzzle Medical Devices Inc. | 90% | |
| Supira Medical | 87% | |
| Magenta Medical | 86% |
For institutional investors. Book with your work email.
Procyrion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Feb 5, 2024 | ||||
| Series D | Jul 9, 2019 | ||||
| Series C | Jan 30, 2018 | ||||
| Series B | Oct 9, 2015 | ||||
| Grant | Jul 15, 2014 | ||||
Corporate Funding | Jan 14, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Procyrion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scientific Health Development | Series B, Series D, Series C |
| Fannin Innovation Studio | Series B, Series D, Series C, Series E, Seed |
| Bluebird Ventures | Series E, Series D |
| National Capital Consortium for Pediatric Device Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
Grew 20% QoQ, from 25 to 30 employees.
- Sep 11, 2026
Monthly visitors increased 31% MoM, reaching 3.1K.
For institutional investors. Book with your work email.
Procyrion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Procyrion's valuation, stock price, and market status.
Is Procyrion a public or private company?
Procyrion is a private company.
What is the current stock price of Procyrion?
Procyrion is a private company, so its shares have no public market price. Caplight tracks Procyrion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Procyrion worth (valuation)?
Valuation information for Procyrion is not publicly available.
Can I buy Procyrion stock?
Procyrion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Procyrion's last funding round?
Procyrion's most recent funding round was Series E on February 5, 2024.
Who are the main investors in Procyrion?
Key investors in Procyrion include Fannin Innovation Studio, Bluebird Ventures.
Will Procyrion IPO soon?
No public IPO plans have been announced for Procyrion.
How can I track Procyrion secondary market activity?
Caplight tracks bids, offers, and trades in Procyrion's shares on secondary markets.